These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese. Wang SX, Xue H, Zou YB, Sun K, Fu CY, Wang H, Hui RT. Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460 [Abstract] [Full Text] [Related]
3. Impaired midwall mechanics and biventricular hypertrophy in essential hypertension. Cuspidi C, Negri F, Giudici V, Sala C, Mancia G. Blood Press; 2010 Aug; 19(4):234-9. PubMed ID: 20218917 [Abstract] [Full Text] [Related]
4. Left and right ventricular structural changes in obese hypertensives. Masaidi M, Cuspidi C, Negri F, Giudici V, Sala C, Zanchetti A, Mancia G. Blood Press; 2009 Aug; 18(1-2):23-9. PubMed ID: 19353408 [Abstract] [Full Text] [Related]
5. Right ventricular hypertrophy in systemic hypertension: an updated review of clinical studies. Cuspidi C, Sala C, Muiesan ML, De Luca N, Schillaci G, Working Group on Heart, Hypertension of the Italian Society of Hypertension. J Hypertens; 2013 May; 31(5):858-65. PubMed ID: 23449015 [Abstract] [Full Text] [Related]
6. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7). Cuspidi C, Giudici V, Negri F, Meani S, Sala C, Zanchetti A, Mancia G. J Hypertens; 2009 Dec; 27(12):2465-71. PubMed ID: 19898252 [Abstract] [Full Text] [Related]
7. Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population. Shipilova T, Pshenichnikov I, Kaik J, Volozh O, Abina J, Kalev M, Lass J, Karai D. Blood Press; 2003 Dec; 12(1):12-8. PubMed ID: 12699130 [Abstract] [Full Text] [Related]
8. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients]. Kartal O, Inal V, Baysan O, Sağlam K. Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224 [Abstract] [Full Text] [Related]
9. Metabolic syndrome and biventricular hypertrophy in essential hypertension. Cuspidi C, Valerio C, Sala C, Negri F, Esposito A, Masaidi M, Giudici V, Zanchetti A, Mancia G. J Hum Hypertens; 2009 Mar; 23(3):168-75. PubMed ID: 18800141 [Abstract] [Full Text] [Related]
10. Prevalence and correlates of aortic root dilatation in patients with essential hypertension: relationship with cardiac and extracardiac target organ damage. Cuspidi C, Meani S, Fusi V, Valerio C, Sala C, Zanchetti A. J Hypertens; 2006 Mar; 24(3):573-80. PubMed ID: 16467661 [Abstract] [Full Text] [Related]
11. Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients. Eguchi K, Kario K, Hoshide S, Ishikawa J, Morinari M, Shimada K. Am J Hypertens; 2005 Jan; 18(1):23-9. PubMed ID: 15691613 [Abstract] [Full Text] [Related]
12. [The role of hypertrophy and left ventricular function on the occurrence of ventricular arrhythmias in arterial hypertension]. Frimm Cde C, Gruppi C, de Moraes AV, Silva HB, Krieger EM, Bellotti G, Pileggi F. Arq Bras Cardiol; 1994 Aug; 63(2):91-6. PubMed ID: 7661717 [Abstract] [Full Text] [Related]
13. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study. Cuspidi C, Meani S, Valerio C, Fusi V, Catini E, Sala C, Magrini F, Zanchetti A. Blood Press; 2005 Aug; 14(1):25-31. PubMed ID: 15823944 [Abstract] [Full Text] [Related]
14. Influence of metabolic syndrome on hypertension-related target organ damage. Mulè G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G, Mongiovì R, Mezzatesta G, Andronico G, Cerasola G. J Intern Med; 2005 Jun; 257(6):503-13. PubMed ID: 15910554 [Abstract] [Full Text] [Related]